EDGAR Filing Documents for 0001144204-14-060628

Form 8-K - Current report:

SEC Accession No. 0001144204-14-060628

Filing Date

2014-10-10

Accepted

2014-10-10 15:24:32

Documents

Period of Report

2014-10-10

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	v391133_8k.htm	8-K	23189
2	EXHIBIT 4.1	v391133_ex4-1.htm	EX-4.1	77473
3	EXHIBIT 5.1(A)	v391133_ex5-1a.htm	EX-5.1(A)	9834
4	EXHIBIT 5.1(B)	v391133_ex5-1b.htm	EX-5.1(B)	9860
5	EXHIBIT 10.1	v391133_ex10-1.htm	EX-10.1	46926
6	EXHIBIT 10.2	v391133_ex10-2.htm	EX-10.2	209309
7	EXHIBIT 99.1	v391133_ex99-1.htm	EX-99.1	10173
8	GRAPHIC	image_008.jpg	GRAPHIC	5121
9	GRAPHIC	image_001.jpg	GRAPHIC	9971
10	GRAPHIC	image_002.jpg	GRAPHIC	9385
	Complete submission text file	0001144204-14-060628.txt		422350

Mailing Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850

Business Address 617 DETROIT STREET, SUITE 100 ANN ARBOR MI 48104 (734) 332-7800

Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)